Switzerland is known for its progressive stance on CBD, yet its legal framework continues to evolve. In recent years, legislative updates, pilot projects, and regulatory debates have signaled bigger changes ahead. In this article, we explore upcoming legal shifts and what they mean for producers, importers, and retailers in the CBD industry.
Recent Legal Milestones
In 2022, Switzerland updated its federal laws regarding cannabinoids. Products with less than 1% THC were formally classified as non-narcotic, making room for clearer regulation of CBD products, particularly for cosmetics, food supplements, and wellness goods.
Meanwhile, Swissmedic and other regulatory bodies have tightened rules around medicinal use, requiring proper licensing and documentation for therapeutic CBD applications.
Adult-Use Cannabis Pilot Programs
Switzerland has launched multiple pilot projects allowing controlled access to recreational cannabis in selected cities. While these pilots are limited in scope, they represent a major step toward broader legalization of cannabis products, including potential market frameworks for higher-THC items in the future.
CBD products are indirectly affected, as regulatory bodies consider how to separate medical, wellness, and adult-use categories more clearly.
Proposed Legal Changes on the Horizon
- Stricter product classifications . Expect new distinctions between cosmetic, food, and therapeutic CBD, possibly requiring separate licenses or approvals depending on the intended use.
- Enhanced packaging and labeling laws . Stricter labeling guidelines are expected, including full cannabinoid content, QR-code traceability, health warnings, and responsible use statements.
- Revised marketing restrictions . Advertising rules may become tighter to prevent unproven medical claims or misleading wellness promises.
- Import/export alignment with the EU Harmonization of standards with the European Union is under discussion, especially around THC thresholds, lab testing, and novel food regulations.
What Businesses Should Do to Prepare
- Monitor government consultations, particularly from Swissmedic, FOPH, and FOAG
- Review current products for compliance with potential new labeling or licensing requirements
- Separate product lines clearly by category (wellness, medical, cosmetic)
- Train staff on legal classifications and Customer communications
- Invest in high-quality lab testing and certification to stay competitive and compliant
Switzerland’s CBD laws are evolving quickly and Future updates are likely to impact everything from product classification to labeling and export procedures. Businesses that adapt early, stay informed, and uphold strict compliance will be well-positioned for long-term success in both the domestic and international markets.
Contacts
Cbd Logistics
6557 – Cama
+41918301114
www.cbdlogistics.eu
info@cbdlogistics.eu
On this website you will find eligible products for EU (THC below 0.30%)
